Optimization of the first line treatment in classical Hodgkin's lymphoma

por Brice, Pauline
Publicado 2018

Autoimmune Hemolytic Anemia and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Rare Association

por Salmeron, Géraldine, Molina, Thierry Jo, Fieschi, Claire, Zagdanski, Anne-Marie, Brice, Pauline, Sibon, David
Publicado 2013

Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients

por Bigenwald, Camille, Galimard, Jacques-Emmanuel, Quero, Laurent, Cabannes-Hamy, Aurélie, Thieblemont, Catherine, Boissel, Nicolas, Brice, Pauline
Publicado 2017

Efficacy of anti-PD1 re-treatment in patients with Hodgkin lymphoma who relapsed after anti-PD1 discontinuation

por Manson, Guillaume, Brice, Pauline, Herbaux, Charles, Bouabdallah, Kamal, Antier, Chloé, Poizeau, Florence, Dercle, Laurent, Houot, Roch
Publicado 2020

Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study

por Zerbit, Jeremie, Chevret, Sylvie, Bernard, Sophie, Kroemer, Marie, Ablard, Charlotte, Harel, Stephanie, Brice, Pauline, Madelaine, Isabelle, Thieblemont, Catherine
Publicado 2020

P109: One-Day Brentuximab-Bendamustine (120mg/m2) every 21 days is a feasible and safe treatment for relapsed/refractory Hodgkin lymphoma

por Moatti, Hannah, Laroque, Marie-Céleste, Renaud, Loïc., Ravdan, Odonchimeg, Schmidt-Hieber, Charlotte, Madelaine, Isabelle, Di Blasi, Roberta, Thieblemont, Catherine, Brice, Pauline
Publicado 2022

Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma

por Chen, Robert, Allibone, Suzanne, Bartlett, Nancy L, Brice, Pauline, Chen, Andy, Pose, Katrina, Rich, Lynn, Bonthapally, Vijay, Garfin, Phillip M, Fanale, Michelle
Publicado 2016

Lupus Erythematosus Tumidus Mimicking Primary Cutaneous Marginal Zone B-cell Lymphoma

por TRAGER, Megan H., RAM-WOLFF, Caroline, BOUAZIZ, Jean-David, BATTISTELLA, Maxime, VIGNON-PENNAMEN, Marie-Dominique, RIVET, Jacqueline, BRICE, Pauline, DE MASSON, Adèle, GESKIN, Larisa J., BAGOT, Martine, DOBOS, Gabor
Publicado 2020

Combined Linkage and Association Studies Show that HLA Class II Variants Control Levels of Antibodies against Epstein-Barr Virus Antigens

por Pedergnana, Vincent, Syx, Laurène, Cobat, Aurélie, Guergnon, Julien, Brice, Pauline, Fermé, Christophe, Carde, Patrice, Hermine, Olivier, Pendeven, Catherine Le-, Amiel, Corinne, Taoufik, Yassine, Alcaïs, Alexandre, Theodorou, Ioannis, Besson, Caroline, Abel, Laurent
Publicado 2014

Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up

por Zinzani, Pier Luigi, Santoro, Armando, Gritti, Giuseppe, Brice, Pauline, Barr, Paul M., Kuruvilla, John, Cunningham, David, Kline, Justin, Johnson, Nathalie A., Mehta-Shah, Neha, Lisano, Julie, Wen, Rachael, Akyol, Alev, Moskowitz, Alison J.
Publicado 2023

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies

por Bartlett, Nancy L, Chen, Robert, Fanale, Michelle A, Brice, Pauline, Gopal, Ajay, Smith, Scott E, Advani, Ranjana, Matous, Jeffrey V, Ramchandren, Radhakrishnan, Rosenblatt, Joseph D, Huebner, Dirk, Levine, Pamela, Grove, Laurie, Forero-Torres, Andres
Publicado 2014

Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT

por Rossi, Cédric, Mounier, Morgane, Brice, Pauline, Safar, Violaine, Nicolas-Virelizier, Emmanuelle, Rey, Philippe, Stamatoullas-Bastard, Aspasia, Alcantara, Marion, Chauchet, Adrien, Reboursière, Emilie, Filliatre, Lauriane, Perrot, Aurore, Garciaz, Sylvain, Salles, Gilles, Coiffier, Bertrand, Ghesquières, Hervé, Casasnovas, René-Olivier
Publicado 2017

Association of Killer Cell Immunoglobulin-Like Receptor Genes with Hodgkin's Lymphoma in a Familial Study

por Besson, Caroline, Roetynck, Sophie, Williams, Fionnuala, Orsi, Laurent, Amiel, Corinne, Lependeven, Catherine, Antoni, Guillemette, Hermine, Olivier, Brice, Pauline, Ferme, Christophe, Carde, Patrice, Canioni, Danielle, Brière, Josette, Raphael, Martine, Nicolas, Jean-Claude, Clavel, Jacqueline, Middleton, Derek, Vivier, Eric, Abel, Laurent
Publicado 2007

Sarcoidosis Occurring After Lymphoma: Report of 14 Patients and Review of the Literature

por London, Jonathan, Grados, Aurélie, Fermé, Christophe, Charmillon, Alexandre, Maurier, François, Deau, Bénédicte, Crickx, Etienne, Brice, Pauline, Chapelon-Abric, Catherine, Haioun, Corinne, Burroni, Barbara, Alifano, Marco, Le Jeunne, Claire, Guillevin, Loïc, Costedoat-Chalumeau, Nathalie, Schleinitz, Nicolas, Mouthon, Luc, Terrier, Benjamin
Publicado 2014

Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma

por Armand, Philippe, Zinzani, Pier Luigi, Lee, Hun Ju, Johnson, Nathalie A., Brice, Pauline, Radford, John, Ribrag, Vincent, Molin, Daniel, Vassilakopoulos, Theodoros P., Tomita, Akihiro, von Tresckow, Bastian, Shipp, Margaret A., Herrera, Alex F., Lin, Jianxin, Kim, Eunhee, Chakraborty, Samhita, Marinello, Patricia, Moskowitz, Craig H.
Publicado 2023

Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients

por Milcent, Benoit, Josseaume, Nathalie, Riller, Quentin, Giglioli, Ilenia, Rabia, Emilia, Deligne, Claire, Latouche, Jean-Baptiste, Hamieh, Mohamad, Couture, Alexandre, Toutirais, Olivier, Lone, Yu-Chun, Jeger-Madiot, Raphaël, Graff-Dubois, Stéphanie, Amorim, Sandy, Loiseau, Pascale, Toubert, Antoine, Brice, Pauline, Thieblemont, Catherine, Teillaud, Jean-Luc, Sibéril, Sophie
Publicado 2019

Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials

por André, Marc P. E., Carde, Patrice, Viviani, Simonetta, Bellei, Monica, Fortpied, Catherine, Hutchings, Martin, Gianni, Alessandro M., Brice, Pauline, Casasnovas, Olivier, Gobbi, Paolo G., Zinzani, Pier Luigi, Dupuis, Jehan, Iannitto, Emilio, Rambaldi, Alessandro, Brière, Josette, Clément‐Filliatre, Laurianne, Heczko, Marian, Valagussa, Pinuccia, Douxfils, Jonathan, Depaus, Julien, Federico, Massimo, Mounier, Nicolas
Publicado 2020

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transp...

por Kersten, Marie José, Driessen, Julia, Zijlstra, Josée M., Plattel, Wouter J., Morschhauser, Franck, Lugtenburg, Pieternella J., Brice, Pauline, Hutchings, Martin, Gastinne, Thomas, Liu, Roberto, Burggraaff, Coreline N., Nijland, Marcel, Tonino, Sanne H., Arens, Anne I.J., Valkema, Roelf, van Tinteren, Harm, Lopez-Yurda, Marta, Diepstra, Arjan, De Jong, Daphne, Hagenbeek, Anton
Publicado 2020

Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group

por Aubrais, Raphaelle, Bouabdallah, Krimo, Chartier, Loic, Herbaux, Charles, Banos, Anne, Brice, Pauline, Sibon, David, Schiano, Jean Marc, Cluzeau, Thomas, Laribi, Kamel, Le Calloch, Ronan, Bellal, Mathieu, Delapierre, Baptiste, Daguindau, Nicolas, Amorim, Sandy, Agbetiafa, Kossi, Chauchet, Adrien, Besson, Caroline, Durot, Eric, Bonnet, Christophe, Fouillet, Ludovic, Bijou, Fontanet, Tournilhac, Olivier, Gaulard, Philippe, Parrens, Marie-Cécile, Damaj, Gandhi
Publicado 2022

P1166: BRIGATINIB IN PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WHO HAVE FAILED BRENTUXIMAB VEDOTIN

por Veleanu, Layla, Tesson, Bruno, Lamant, Laurence, Marçais, Ambroise, Bruneau, Julie, Kaltenbach, Sophie, Brouzes, Chantal, Degoutte, Charlotte, Moraly, Josquin, Villarese, Patrick, Lhermitte, Ludovic, Latiri, Mehdi, Hure, Gregoire, Chauchet, Adrien, Delette, Caroline, Grosleron, Sylvie, Toussaint, Elise, Cabrera, Quentin, Brice, Pauline, Gros, Francois-Xavier, Clavert, Aline, Oberic, Lucie, Legoff, Marielle, Cereja, Sophie, Meggetto, Fabienne, Macintyre, Elizabeth, Asnafi, Vahid, Sibon, David
Publicado 2023